Skip to main content
S 3220 118th Congress Senate Health

A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.

Introduced: December 6, 2023 Introduced by: Kelly, Mark Democratic · Arizona See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 2, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Nov 2, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill expands the priority-review voucher program for tropical diseases to include coccidioidomycosis (also known as Valley fever). A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.

What's happening now November 2, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 2
  • HR 6227 Related bill Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023
  • S 3464 Related bill FORWARD Act of 2023
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 4
All 4 Democratic 2
D
Merkley, Jeff
Oregon · Mar 6, 2024
 D
Hickenlooper, John W.
Colorado · Jan 31, 2024
Mullin, Markwayne
· Dec 6, 2023
Sinema, Kyrsten
· Nov 2, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3220: A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.. 118th Congress. Open America. https://openamerica.io/bill/118-S-3220/
MLA
"S. 3220: A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-3220/.
Bluebook (legal)
S. 3220, 118th Cong. (2026), https://openamerica.io/bill/118-S-3220/.
Markdown link
[S. 3220: A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.](https://openamerica.io/bill/118-S-3220/)
Report a problem